EGFR and cancer: Given the positive correlation between EGFR mutations and “lymphocyte depletion” phenotype in the recent pan-cancer analysis of The Cancer Genome Atlas (TCGA) [37], we performed a comprehensive TCGA-based analysis of the TME associated with EGFR mutations, with a particular focus on lung adenocarcinomas (LUADs).